Mighop-Plus Tablet 10's
₹103.5*
MRP ₹115
10% off
₹98*
MRP ₹115
15% CB
₹17 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Mighop-Plus Tablet is used to treat migraine. Migraine is a medical condition that involves severe throbbing pain or a pulsing sensation on one side of the head. Severe and recurrent headaches are one of the characteristic symptoms of migraine. Its symptoms include nausea, vomiting, difficulty speaking, numbness or tingling, and sensitivity to light and sound.
Mighop-Plus Tablet consists of 'Propranolol' (beta-blocker) and 'Flunarizine' (calcium channel blocker). Propranolol has anxiolytic (anxiety-reducing), anti-arrhythmic (treats abnormal heart rhythms), and antihypertensive (reduces blood pressure) properties. Propranolol works by reducing cerebral (brain) blood flow by directly acting on the brain's blood vessels. It also inhibits the cortical spreading of depression and electrical activity in the brain that causes pain and inflammation. It effectively treats and reduces the severity and frequency of migraine headaches. Flunarizine belongs to the class of calcium channel blockers. It improves blood flow and dilates blood vessels in the brain, thereby preventing headaches caused by migraine. It is also used to treat vertigo (spinning sensation).
Your doctor will decide the dose and duration based on the severity of your pain. Common side effects of Mighop-Plus Tablet include dry weight gain, slow heart rate, tiredness, depression, drowsiness, abnormal dreams, and cold extremities (hands and feet). These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you use any prescription and non-prescription medications you are taking, including other vitamins, before starting Mighop-Plus Tablet . Mighop-Plus Tablet may cause weight gain in some cases, so avoid eating junk and eat a healthy, balanced diet, including home-cooked food. Consult your doctor before taking Mighop-Plus Tablet if you are pregnant, planning for pregnancy or breastfeeding. Avoid consuming alcohol along with Mighop-Plus Tablet as it could lead to increased drowsiness.
Mighop-Plus Tablet is used to treat migraine. It consists of 'Propranolol' and 'Flunarizine'. Propranolol is a beta-blocker and has anxiolytic (anxiety-reducing), anti-arrhythmic, and antihypertensive properties. It works by lowering cerebral (brain) blood flow and inhibits cortical spreading depression, as well as electrical activity in the brain that causes pain and inflammation. It reduces the severity and frequency of migraine headaches. Flunarizine is a channel blocker that improves blood flow and dilates blood vessels in the brain, thereby preventing headaches caused by migraine.
Inform your doctor if you have any history of liver or kidney diseases, breathing problems (asthma, bronchitis, emphysema), diabetes, heart failure, heart rhythm problems (sinus bradycardia, Wolff-Parkinson-White syndrome, atrioventricular block), overactive thyroid, blood circulation problems (Raynaud's disease), adrenal gland tumour (pheochromocytoma), depression, metabolic acidosis (excess acid in the blood), and myasthenia gravis (muscle weakness) before starting Mighop-Plus Tablet . Please consult your doctor if you are pregnant and planning to conceive if the doctor advised you Mighop-Plus Tablet . Avoid consuming alcohol along with Mighop-Plus Tablet as it could lead to increased dizziness and drowsiness.
Drug-Drug Interaction: Mighop-Plus Tablet may interact with mood disorder medicines (alprazolam, quetiapine, aripiprazole), drugs treating sleeping problems (zolpidem), respiratory drugs (diphenhydramine), antidepressants (sertraline, duloxetine, fluoxetine), and fits medicine (carbamazepine, phenytoin).
Drug-Food Interaction: Alcohol may cause dizziness and drowsiness when taken with Mighop-Plus Tablet .
Drug-Disease Interaction: Before using Mighop-Plus Tablet , let your doctor know if you have any liver, kidney or heart diseases, asthma, depression, muscle disorders, metabolic acidosis, diabetes, and alcohol dependency.
Let your doctor know that you are taking Mighop-Plus Tablet if you are undergoing any medical tests.
Beta-blockers like Propranolol can mask hypoglycaemia symptoms (low blood sugar) or hyperthyroidism (high thyroid levels).
It is advised to inform your doctor if you have diabetes or thyroid disease before using Mighop-Plus Tablet .
Beta-blockers can also cause changes in serum lipid profiles. Patients with pre-existing hyperlipidaemia (high lipid levels) should be closely monitored if using Mighop-Plus Tablet .
Migraine: It is a medical condition that involves severe throbbing pain or a pulsing sensation on one side of the head. Severe and recurrent headaches are one of the characteristic symptoms of migraine. Symptoms of migraine may include nausea, vomiting, difficulty speaking, numbness or tingling, and sensitivity to light and sound. Migraine can be triggered by various factors like foods (eggs, tomatoes, onions, dairy products, wheat, pasta, citrus fruits, nitrites found in foods, alcohol, and red wine), hormonal changes, sleep changes, stress, loud noises, and medications.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Mighop-Plus Tablet . Alcohol intake, along with Mighop-Plus Tablet , may cause increased dizziness and drowsiness.
Pregnancy
Caution
Please consult your doctor if you are pregnant or planning to conceive before using Mighop-Plus Tablet .
Breast Feeding
Caution
Please consult your doctor before taking Mighop-Plus Tablet if you are a lactating mother.
Driving
Caution
Mighop-Plus Tablet may make you feel drowsy. Do not drive or operate machinery if you experience drowsiness.
Liver
Caution
Therapy with propranolol should be administered cautiously in patients with liver disease. Please consult your doctor if you have a history of liver impairment/liver disease.
Kidney
Caution
Plasma clearance of Propranolol in Mighop-Plus Tablet is reduced in patients with renal failure. Please consult your doctor if you have a history of kidney impairment/kidney disease.
Children
Safe if prescribed
Mighop-Plus Tablet is safe to use for children below 12 years of age when prescribed by the doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes